Answers are grounded in this paper and cite their sources.
Procurement biopsies are commonly used in organ acceptance decisions despite inconsistent access to experienced renal pathologists and heterogeneous approaches to criteria, scoring, and interpretation. Ongoing study and consensus building are needed to direct procurement biopsy practice toward increasing organ utilization and reducing allocation inefficiency.
No takes yet. Share an insight, caveat, or question.
Lentine et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: